D3 Pharma

About D3 Pharma

D3 Pharma is a specialty pharmaceutical company established in 2009 with the principal objective of providing European and worldwide access to clinically effective, high-strength vitamin D3 products for the treatment of vitamin D deficiency, insufficiency and associated conditions. 

D3 Pharma, and it's partner Actavis UK Limited, a subsidiary of Accord Healthcare Ltd., successfully developed and gained UK Marketing Authorisations for the first range of high-strength vitamin D3 products, which are marketed under the trade name Plenachol®.

D3 Pharma continues to broaden its vitamin D3 product range to address areas of high unmet need, particularly for the paediatric and geriatric population worldwide.

For further information regarding licensing or partnering opportunities, please contact us via email at: info@d3-pharma.com